Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation.

scientific article published in January 2010

Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CLC.20689
P8608Fatcat IDrelease_hjgd2qgw45d53ei3iepxwqb664
P932PMC publication ID6652986
P698PubMed publication ID20063294
P5875ResearchGate publication ID40900960

P2093author name stringLi Li
Wang Min
Huang Jin-Yu
Huang Shi-Eng
Pei De-An
Xu Zheng-Ming
Xu Zhi-Yun
Yao Qiang
P2860cites workMineralocorticoid action: target tissue specificity is enzyme, not receptor, mediatedQ28281477
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study InvestigatorsQ28372091
Mineralocorticoid selectivity: molecular and cellular aspectsQ33888900
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarctionQ34187441
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trialQ34246898
Atrial fibrosis and the mechanisms of atrial fibrillationQ34576855
The new biology of aldosteroneQ36185968
11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone actionQ36217956
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cellsQ38330461
The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat.Q38351057
Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillationQ43777099
Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.Q44064962
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trialsQ44456364
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failureQ44468973
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled studyQ44672306
Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failureQ45276007
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) studyQ45285131
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).Q46466522
Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heartQ71844423
Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunctionQ78045101
Mounting evidence that fibrosis generates a major mechanism for atrial fibrillationQ81432055
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronismQ81661632
Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failureQ83308267
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectAtrial FibrillationQ815819
hydroxysteroidQ2157080
P304page(s)23-29
P577publication date2010-01-01
P1433published inClinical CardiologyQ4502312
P1476titleIncreased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation
P478volume33

Reverse relations

cites work (P2860)
Q36494721Aldosterone and cardiovascular disease: the heart of the matter
Q33775560Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling
Q38124345Mineralocorticoid receptor and cardiac arrhythmia
Q37496071Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation
Q37622571The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation

Search more.